According to UNAIDS and US CDC guidance, people living with HIV should get vaccinated against Covid-19; none of the approved vaccines or those under development are live vaccines.
One in five people living with HIV in Malaysia reported a decrease in taking routine HIV tests, while one-third of individuals at-risk reduced frequency of tests.
The recent price for Tivicay in Malaysia, Azerbaijan, Belarus, and Kazakhstan was reportedly between US$1,800 (RM7,345) and US$2,160 (RM8,814) per patient annually.